Drug Observance and Side Effects of Cytoreductive Drugs in PV and ET Patients

A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients

NCT02213978 ·Status: COMPLETED

Evaluation of Reporting of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors Associated Cardiovascular Adverse reactioN.

NCT03413176 ·Status: COMPLETED

Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism

NCT02923115 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Pharmacokinetics, Safety and Pharmacodynamics After Multiple Oral Doses of Dabigatran Etexilate Capsule in Healthy Japanese and Caucasian Male Subjects

NCT02171468 ·Status: COMPLETED ·Phase: PHASE1

Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection

NCT02247414 ·Status: COMPLETED ·Phase: PHASE4

Assessment of the Anti-inflammatory Effect of Heparin Infusion Versus Subcutaneous Injection in Septic Patients

NCT04313790 ·Status: COMPLETED ·Phase: PHASE2

Six Years of Follow-up After Idiopathic Venous Throbmoembolism

NCT02884934 ·Status: COMPLETED

Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism.

NCT04141254 ·Status: UNKNOWN ·Phase: PHASE3

Monitor System for the Safety of Dabigatran Treatment

NCT02414035 ·Status: COMPLETED

Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure

NCT03206372 ·Status: RECRUITING

Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants

NCT03742336 ·Status: COMPLETED ·Phase: PHASE1

Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera

NCT05548062 ·Status: ACTIVE_NOT_RECRUITING

Immature Plateletes in the Etiopathology of Deep Venous Thrombosis

NCT02361294 ·Status: COMPLETED

Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer

NCT03180567 ·Status: UNKNOWN ·Phase: NA

Evaluation of the Impact of an Expert Opinion During the Management of Patients With Severe Bleeding on Oral Anticoagulants.

NCT05928091 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets

NCT05627375 ·Status: RECRUITING ·Phase: PHASE3

Comparative Effectiveness and Safety Between Warfarin and Dabigatran

NCT03254134 ·Status: COMPLETED

Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study

NCT02303431 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age

NCT01773174 ·Status: WITHDRAWN ·Phase: PHASE2

Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia

NCT05641142 ·Status: RECRUITING ·Phase: NA

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment

NCT02182024 ·Status: COMPLETED ·Phase: PHASE1

Safety, Pharmacodynamics and Pharmacokinetics After Single Oral Administration of Dabigatran Etexilate Capsule in Healthy Subjects

NCT02171455 ·Status: COMPLETED ·Phase: PHASE1

Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies

NCT03157154 ·Status: COMPLETED

Determine the Frequency of a HTPPE in 5 Years (± on 1 Year) After a First Episode of Idiopathic Pulmonary Embolism.

NCT01894204 ·Status: TERMINATED ·Phase: NA

Secondary Prevention of Venous Thrombo Embolism (VTE).

NCT00329238 ·Status: COMPLETED ·Phase: PHASE3